Infections are a common complication and cause of mortality in transplant and cystic fibrosis patients. Such infections are potentially treatable if appropriate antimicrobials are administered early.

Lung transplant, bone marrow transplant and cystic fibrosis patients bear many similarities to ICU patients with poor outcomes associated with suboptimal antimicrobial dosing.

This population of patients currently have only sparse pharmacokinetic data yet are routinely treated with antimicrobial doses validated in healthy volunteers. A much better characterisation of antimicrobial pharmacokinetics in these patients is required.

Project members

Jason Roberts

Professor Jason Roberts

Director
CRE RESPOND
Deputy Director
Frazer Institute
NHMRC Leadership Fellow
The University of Queensland
Pharmacist Consultant
Royal Brisbane & Women’s Hospital

Professor Jeffrey Lipman

Critical Care Research, Translation and Training Lead
CRE RESPOND
Emeritus Professor
Frazer Institute

Professor Monica Slavin

Immunocompromised Host Research and Translation Lead
CRE RESPOND
Director of the Infectious Diseases Department
Peter McCallum Cancer Centre, Victoria, Australia

Professor Jordi Rello

Professor of Medicine
Universitat Autònoma de Barcelona
Chief of the Critical Care Department
Vall d'Hebron University Hospital